SCHEMBL21933465

SCHEMBL21933465

Cc1c(CN2CCN(C(=O)C(C)O)CC2)cc2c(N3CCOCC3)nc(-c3cnc(N)cc3C(F)(F)F)nn12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 20/20 0.54
PIK3R1 P27986 9/20 0.54
PIK3CD O00329 7/20 0.53
PIK3CB P42338 5/20 0.53
PIK3CG P48736 4/20 0.53
MTOR P42345 6/20 0.47
PIK3C2B O00750 2/20 0.47
PRKDC P78527 2/20 0.47
PIK3C3 Q8NEB9 2/20 0.47
PIK3C2A O00443 1/20 0.47
STK10 O94804 1/20 0.47
PAK4 O96013 1/20 0.47
ABL1 P00519 1/20 0.47
EGFR P00533 1/20 0.47
FGR P09769 1/20 0.47
FER P16591 1/20 0.47
PRKCA P17252 1/20 0.47
JAK1 P23458 1/20 0.47
TEC P42680 1/20 0.47
SYK P43405 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21929466 1.00 PIK3CA (0.54) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21933482 0.91 PIK3CA (0.55) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21929432 0.89 PIK3CA (0.59) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL22006205 0.89 PIK3CA (0.53) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21929582 0.88 PIK3CA (0.53) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21929580 0.87 PIK3CA (0.58) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21929453 0.87 PIK3CA (0.58) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21929663 0.87 PIK3CA (0.55) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL23434839 0.86 PIK3CA (0.49) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG
SCHEMBL21929578 0.85 PIK3CA (0.56) PIK3CAPIK3R1PIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643717-B1 7-SUBSTITUTED PYRROLE TRIAZINE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND PREPARATION METHOD THEREFOR AND USES THEREOF SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-06-02 EP disclosed
EP-3643717-A1 7-SITE SUBSTITUTED PYRROLE TRIAZINE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND PREPARATION METHOD THEREFOR AND USES THEREOF Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2020-04-29 EP disclosed